Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited

PAR.AX
Paradigm Biopharmaceuticals LimitedAU flagAustralian Securities Exchange
0.18
AUD
- -
- -
75.84MMarket Cap

Total Valuation

Paradigm Biopharmaceuticals Limited carries a market capitalization of 75.84M, placing it among publicly traded companies globally.

Market Cap75.84M
Enterprise ValueN/A

Stock Price Statistics

Paradigm Biopharmaceuticals Limited's stock has declined approximately -59.30233% over the past 52 weeks. The 50-day moving average sits at 0.17, while the 200-day moving average is 0.28.

Beta (5Y)N/A
52-Week Price Change-59.30233%
50-Day Moving Average0.17
200-Day Moving Average0.28
Average Volume (20 Days)N/A

Stock Splits

Paradigm Biopharmaceuticals Limited's most recent stock split took place on November 1, 2023 with a 250:257 split ratio.

Last Split Date11/1/2023
Split Ratio250:257